cancer drug resistance - Robuta Search

https://pubmed.ncbi.nlm.nih.gov/34359591/?dopt=Abstract Breast Cancer Drug Resistance: Overcoming the Challenge by Capitalizing on MicroRNA and Tumor... The clinical management of breast cancer reaches new frontiers every day. However, the number of drug resistant cases is still high, and, currently, this... cancer drug resistance https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2021.740720/full Frontiers | High ATP Production Fuels Cancer Drug Resistance and Metastasis: Implications for... Recently, we presented evidence that high mitochondrial ATP production is a new therapeutic target for cancer treatment. Using ATP as a biomarker, we isolate... cancer drug resistance https://news.asu.edu/20230315-study-identifies-new-genetic-signatures-breast-cancer-drug-resistance Study identifies new genetic signatures of breast cancer drug resistance | ASU News A new ASU study has pinpointed more than 30 breast cancer gene targets that are involved in drug resistance to a leading chemotherapy treatment. cancer drug resistance https://cancer.illinois.edu/ccil-seed-grant-supports-study-of-drug-resistance-in-cancer-therapy/ CCIL Seed Grant Supports Study of Drug Resistance in Cancer Therapy | Cancer Center at Illinois https://www.helsinki.fi/en/researchgroups/systems-biology-of-drug-resistance-in-cancer/data-access Data Access | Systems Biology of Drug Resistance in Cancer | University of Helsinki Here we are detailing the documents necessary for applicants to our EGA datasets. data access systems biology drug resistance https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2022.1070479/full Frontiers | Application of engineered extracellular vesicles to overcome drug resistance in cancer Targeted therapies have significantly improved survival rates and quality of life for many cancer patients. However, on- and off-target side toxicities in no... extracellular vesicles https://www.frontiersin.org/journals/cell-and-developmental-biology/articles/10.3389/fcell.2022.971477/full Frontiers | Editorial: Drug resistance in lung cancer chemotherapy and personalized chemotherapy Lung cancer is one of the most common causes of cancer-related death, and non-small cell lung cancer (NSCLC) accounts for more than 80% of all lung cancers. ... drug resistance lung cancer frontiers editorial chemotherapy https://www.sciencedaily.com/releases/2015/05/150504121035.htm Multiple types of resistance to new lung cancer drug identified | ScienceDaily After identifying three different types of resistance to a promising investigational lung cancer drug in a phase 1 trial, a team of researchers says new... types of lung cancer multiple resistance https://www.helsinki.fi/en/researchgroups/systems-biology-of-drug-resistance-in-cancer/software Software | Systems Biology of Drug Resistance in Cancer | University of Helsinki All our software is open. A few of our major development projects are listed below. software systems drug resistance biology cancer university https://www.sciencedaily.com/releases/2014/04/140403084404.htm In vitro tests show that clinically tested drug overcomes resistance to potential new cancer... Results from laboratory experiments carried out by a team of molecular biologists have identified a strategy for overcoming resistance to a new therapeutic... in vitro tests https://research-portal.st-andrews.ac.uk/en/publications/cell-population-heterogeneity-and-evolution-towards-drug-resistan/ Cell population heterogeneity and evolution towards drug resistance in cancer: biological and... drug resistance cell population heterogeneity evolution https://www.ucsf.edu/news/2016/05/402916/hybrid-cancer-drug-could-be-resistance-resistant Archive: Hybrid Cancer Drug Could Be Resistance-Resistant | UC San Francisco A team of cancer researchers led by scientists at UCSF and Memorial Sloan Kettering Cancer Center in New York have developed a first-of-its-kind hybrid drug... cancer drug could be archive hybrid